Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia

SIMPLE SUMMARY: Chimeric antigen receptor (CAR) therapy has increased treatment options for many patients who have failed standard chemotherapy. So far, CAR therapy has been used more frequently in B-cell mediated cancers due to unique challenges posed by patients with acute myeloid leukemia (AML) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Marvin-Peek, Jennifer, Savani, Bipin N., Olalekan, Oluwole O., Dholaria, Bhagirathbhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833567/
https://www.ncbi.nlm.nih.gov/pubmed/35158765
http://dx.doi.org/10.3390/cancers14030497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833567/
https://www.ncbi.nlm.nih.gov/pubmed/35158765
http://dx.doi.org/10.3390/cancers14030497

Ejemplares similares